Scaling-Up hPSC-Derived Cardiomyocytes for Preclinical and Therapeutic Applications
Learn how the STEMdiffâ„¢ Cardiomyocyte Expansion Kit enables the production of over 600 million hPSC-derived ventricular cardiomyocytes in just 30 days. Presented by Dr. Vincenzo Macri, this webinar explores the role of hPSC-derived cardiomyocytes in repairing ventricular damage, the global impact of heart disease, and key tools for assessing cell quality and function. Watch now to discover best practices for scaling up cardiomyocyte production for preclinical and therapeutic applications.
Publish Date:
February 21, 2025
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to º£½ÇÆƽâ°æ Technologies Canada Inc. and its subsidiaries and affiliates (“º£½ÇÆƽâ°æâ€) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
Modeling Arrhythmias Using hPSC-Derived Cardiomyocytes and Tracking Their Excitability
Publish Date: August 14, 2017 -
Robust Workflows for the Expansion of PSCs in 3D Suspension Culture
Publish Date: July 29, 2022 -
Highly Efficient Single-Cell Human Pluripotent Stem Cell Cloning and Robust Cardiomyocyte Differentiation
Publish Date: July 03, 2017
Explore Our Products
-
STEMdiffâ„¢ Cardiomyocyte Dissociation Kit
For dissociation of hPSC-derived cardiomyocytes -
STEMdiffâ„¢ Cardiomyocyte Expansion Kit
Serum-free kit for the expansion of early-stage human PSC-derived cardiomyocytes
